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Summary
Background.— Catheter ablation of atrial ﬁbrillation (AF) focuses on pulmonary vein isolation
(PVI), but the procedure is associated with signiﬁcant X-ray exposure. Few data exist con-
cerning the combination of remote magnetic navigation (RMN) and a new three-dimensional
non-ﬂuoroscopic navigation system (Carto® 3), which facilitates precise catheter navigation
and limits X-ray exposure.
Aims.— To assess the efﬁcacy and extent of ﬂuoroscopic exposure associated with the combi-
nation of RMN and the Carto 3 system in patients requiring AF ablation.
Methods.— Between January and September 2011, catheter ablation was performed remotely
using the Carto 3 system in 81 consecutive patients who underwent PVI for symptomatic drug-
refractory AF. The radiofrequency generator was set to a ﬁxed power≤ 35W. The primary
endpoint was wide-area circumferential PVI conﬁrmed by spiral catheter recording during abla-
tion and including additional lesion lines (left atrial roof and coronary sinus defragmentation)
or complex fractionated atrial electrograms for persistent AF. Secondary endpoints included
procedural data, complications and freedom from atrial tachycardia (AT)/AF.
Abbreviations: 3D, three-dimensional; AF, atrial ﬁbrillation; AT, atrial tachycardia; RF, radiofrequency; RMN, remote magnetic navigation;
VKA, vitamin K antagonist.
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Results.— Mean age was 60± 9 years; 20% were women; 73% had symptomatic paroxysmal
AF; 27% had persistent AF. The CHA2DS2-VASc score was 1.2± 1. Median procedure time
was 3.5± 1 hours; median total X-ray exposure time was 13± 7minutes; transseptal punc-
ture and catheter positioning took 8± 4minutes, left atrium electroanatomical reconstruction
1± 4minutes and catheter ablation 3.5± 5minutes. Recurrences were AT (n = 3; 3.7%), parox-
ysmal AF (n = 8; 9.9%) and persistent AF (n = 4; 4.9%); redo ablation was performed in these
15 (19%) patients. After a median follow-up of 15± 6months and a single procedure, 71% of
patients were free of symptoms; 84% remained asymptomatic after two procedures.
Conclusions.— RMN with irrigated catheters combined with the Carto 3 system can be effec-
tively performed in patients requiring AF ablation with minimal use of ﬂuoroscopy, but larger
randomized studies are warranted.
© 2013 Elsevier Masson SAS. All rights reserved.
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Résumé
Contexte.— L’isolation électrique des veines pulmonaires (VP) est la cible principale du traite-
ment par radiofréquence (RF) de la ﬁbrillation atriale (FA), mais ces procédures sont longues
et exposent de manière signiﬁcative aux rayons X (RX). Dans ce contexte, peu de données sont
disponibles dans la littérature sur l’utilisation combinée de la navigation par robot magnétique
(NRM) et du nouveau système de cartographie 3-D (Carto® 3 system).
Objectifs.— L’objectif de cette étude prospective était d’évaluer l’efﬁcacité et le niveau
d’exposition aux RX lors de l’utilisation combinée de la NRM couplée au système Carto 3 au
cours de l’ablation de FA.
Méthodes.— Entre janvier et septembre 2011, l’utilisation combinée des deux systèmes a été
réalisée chez 81 patients consécutivement. Une isolation exclusive des VP était réalisée pour
les patients avec FA paroxytique alors que les patients avec FA persistante avaient une isolation
circonférentielle des VP couplée à une ligne sur le toit et une défragmentation du sinus coron-
aire. Les objectifs secondaires étaient basés sur l’évaluation des données des procédures, des
complications et des récidives de troubles rythmiques auriculaires.
Résultats.— La moyenne d’âge de la population était de 60± 9 ans (20 % femmes), avec FA
paroxystique (73 %) ou persistante (27 %). Le score de CHA2DS2-VASc était de 1,2± 1. Le temps
médian de procédure était de 3,5± 1 heures et le temps médian d’exposition aux RX était
de 13± 7min; le temps nécessaire au cathétérisme transeptal était de 8± 4min, le temps
pour la reconstruction anatomique de 1± 4min, alors que le temps moyen d’ablation était de
3,5± 5min. Trois patients ont récidivé sous la forme de tachycardie atriale (3,7 %), huit en FA
paroxystique (9,9 %), et quatre en FA persistante (4,9 %). Après un suivi moyen de 15± 6mois
et une seule procédure, 71 % des patients étaient asymptomatiques, alors que 84% restaient
asymptomatiques après deux procédures. Une nouvelle séance de RF a été réalisée chez 15
(19 %) patients.
Conclusions.— L’utilisation combinée du robot magnétique au système de cartographie (Carto
3) représente une alternative efﬁcace pour l’ablation de la FA avec une utilisation très faible
de rayons X.
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ackground
ver the past few years, radiofrequency (RF) therapy has
ad a decisive place in the treatment of complex arrhyth-
ias and, more particularly, atrial ﬁbrillation (AF) [1—5].
his technology requires experienced operators with special
kills in manipulating catheters in difﬁcult clinical situa-
ions, so this intervention may involve long, tedious and
otentially risky procedures [1,3—5]. Catheter technology
s a major limitation to the manual method, as catheter
obility is limited by the transmission of the torque, which
epends on vessel tortuosity, catheter orientation in the
eart and catheter rigidity or instability. During these proce-
ures, the operator is exposed not only to X-rays, but also to
bnormal fatigue, which may lead to a loss of concentration.
o
m
ts droits réservés.
his decreased concentration may result in delayed anal-
sis, a lengthened procedure and an increased risk of
omplications. AF treatment is increasingly used in electro-
hysiological laboratories due to the prevalence of AF (2—3%
f the population aged > 60 years) and the low beneﬁt/risk
atio of antiarrhythmic drugs compared with RF techniques,
s shown in several randomized studies [1,6—8]. The current
rend favours technology that is similar to or more effec-
ive than manual RF techniques, but is safer in terms of
otential complications and other variables such as X-ray
xposure for patient and operator. Such technology should
ventually allow the management of more patients with-
ut adverse effects on the operators’ health. The remote
agnetic navigation (RMN) system appears to be a futuris-
ic technology beneﬁting from a very favourable beneﬁt/risk
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ratio for both the patient and operator [9—14]. Several other
technological innovations facilitating AF ablation have been
proposed, but there are few data available concerning the
combination of RMN with a new three-dimensional (3D) non-
ﬂuoroscopic navigation system (Carto® 3; Biosense Webster,
CA, USA), which facilitates precise catheter navigation and
limits X-ray exposure [15—23].
This prospective study aimed to evaluate the efﬁcacy and
extent of ﬂuoroscopic exposure associated with the combi-
nation of RMN and the Carto 3 system in patients requiring
AF ablation [21].
Methods
Catheter ablation was performed remotely using the Niobe II
RMN system (Stereotaxis; St. Louis, MO, USA) combined with
a new 3D non-ﬂuoroscopic navigation system (Carto 3 sys-
tem) in 81 consecutive patients who underwent pulmonary
vein disconnection for symptomatic drug-refractory AF.
Electrophysiological procedures
All patients received anticoagulation therapy with vita-
min K antagonists (VKAs) for at least 2months prior to
the procedure (target international normalized ratio, 2—3).
Therapeutic anticoagulation was maintained with intra-
venous or low-molecular-weight heparin following VKA
discontinuation, starting 3 days before the intervention.
Transoesophageal echocardiography was performed within
48 hours before the procedure to exclude left atrial throm-
bus. VKAs were resumed the day after the procedure
and effective anticoagulation was maintained with hep-
arin until the international normalized ratio was > 2.0.
Surface electrocardiograms and bipolar endocardial elec-
trograms (ﬁltered from 30 to 500Hz) were continuously
monitored and stored on a computer-based digital ampli-
ﬁer/recorder system. A deﬂectable quadripolar catheter
(5mm interelectrode spacing; Xtrem; ELA Medical, Mon-
trouge, France) was positioned in the coronary sinus for
pacing and recording. The left atrium was accessed by a
patent foramen ovale, when present, or by transseptal punc-
ture. A guidewire was introduced into the left atrium using
an 8F long sheath. The sheath was perfused during the
procedure with heparinized solution (3000U of heparin in
500mL of sodium chloride 0.9% at a rate of 150mL/h).
A multipolar deﬂectable catheter (Lasso; Biosense Web-
ster, Diamond Bar, CA, USA) was inserted through the long
sheath to map the pulmonary vein ostia for all ablation pro-
cedures. RF ablation was performed using a 3.5mm open
irrigated-tip magnetic ablation catheter (NaviStar® RMT
ThermoCool®; Biosense Webster, Diamond Bar, CA, USA).
The catheter was advanced into the left atrium through a
second transseptal puncture. The venous sheath was then
withdrawn in the right atrium and continuously perfused.
Following transseptal puncture, intravenous unfractionated
heparin was administered as a bolus (7500 units); additional
boluses were given throughout the procedure to maintain an
activated clotting time of≥ 300 seconds. Activated clotting
time was determined 30minutes after transseptal puncture
and every 30minutes thereafter. When the activate clotting
time was < 300 seconds, an additional bolus of 2500 units was
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dministered. Deep sedation was achieved using intravenous
albuphine and midalzolam.
adiofrequency catheter ablation procedures
egardless of the study group, the endpoints of ablation
ere isolation of the pulmonary veins, deﬁned by complete
limination or dissociation of pulmonary potentials vali-
ated with a circumferential mapping catheter in all cases
paroxysmal and persistent AF), and the creation of linear
esions interconnecting the upper pulmonary vein ostia (roof
ine).
RF was applied using an open irrigated-tip catheter with
power output < [≤?] 35W close to the pulmonary vein ostia
nd 30W for the rooﬂine or while creating coronary sinus dis-
onnection. Irrigation with sodium chloride 0.9% at a rate of
0—35mL/min was employed to maintain a tip temperature
f < 43 ◦C.
arto 3 system features
he Carto 3 system allows for real-time Advanced Catheter
ocationTM and visualization of both ablation and circular
apping catheters (NaviStar and Lasso catheters) (Fig. 1).
he catheter location display is identical to that of the ﬂu-
roscopic view.
The Carto 3 system combines electromagnetic technology
as in the Carto XP system; Biosense Webster, CA, USA) with
ew advanced catheter location technology that enables
isualization of multiple catheters without ﬂuoroscopy.
rieﬂy, advanced catheter location is an impedance-based
atheter localization system that enables precise cardiac
apping and navigation with multiple electrodes. Six elec-
rode patches are attached to the body surface, which
onstantly monitor the current emitted at a frequency
nique to each individual catheter electrode. Each elec-
rode patch is also equipped with a magnetic sensor,
nabling 3D localization. Currents detected at the patches
elate the electrode’s 3D positioning inside the human
ody. The Carto 3 system’s ability to visualize manipula-
ion and placement of circular mapping catheters in each
ein may further reduce ﬂuoroscopy time. This new system
lso improves catheter stability during ablation and eases
dentiﬁcation of each catheter electrode-pair position. Visu-
lization of catheters and electrode-pairs is provided via
real-time on-screen display of a geometrically reliable
con representing the distal part of the Lasso catheter along
ith the electrodes’ positions. Left atrial reconstruction
as obtained using a fast anatomical map algorithm. This
ethod takes a continuous (non-gated) record of the NaviS-
ar catheter’s movements. Based on this volume sampling,
surface reconstruction was built in accordance with the
et resolution level to prevent left atrial volume overesti-
ation due to respiratory movements. Once the map was
ompleted, a 3D computed tomography scan was performed
o optimize the left atrial reconstruction (Fig. 2).
emote magnetic navigation systemhe RMN system (Niobe II; Stereotaxis, Inc., St. Louis, MO,
SA) is a technological platform that uses a steerable mag-
etic ﬁeld to remotely guide a supple catheter inside the
426 A. Da Costa et al.
Figure 1. The Carto 3 system allows for real-time Advanced Catheter LocationTM and visualization of both ablation and circular mapping
catheters (NaviStar RMT and Lasso; Biosense Webster, Diamond Bar, CA, USA).
Figure 2. Left atrial reconstruction was obtained using a fast anatomical map algorithm. This method takes a continuous (non-gated)
record of the movements of the NaviStar catheter (Biosense Webster, Diamond Bar, CA, USA). Based on this volume sampling, a surface recon-
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can was performed to optimize the left atrial reconstruction.
eart [9—14]. The steerable magnetic ﬁeld contains two
iant computer-controlled 1.8-tonne magnets that are pos-
tioned on opposite sides of the ﬂuoroscopy table (Fig. 3). A
agnetic ﬁeld of 0.08—0.1 Tesla is generated (according to
he initial choice), such that the three small magnets that
re incorporated parallel to the tip of the RF catheter allow
or 3D navigation (Fig. 4). The magnetic ﬁeld is applied to a
heoretical cardiac volume of 20 cm× 20 cm. The catheter
ip may be directed very precisely using a vector-based com-
uter system (Navigant system; Stereotaxis Inc., St. Louis,
w
s
U
ce map was completed, a three-dimensional computed tomography
O, USA) (Fig. 5). This system operates by aligning the
atheter relative to the magnetic ﬁeld generated so that
he movement of the catheter depends on changes in the
irection of the two magnets in relation to each other. A
omputerized motor drive system (Cardiodrive; Stereotaxis
nc., St. Louis, MO, USA) advances or retracts the catheters,
hile its orientation in space requires a computerized work
tation (Navigant 2.1; Stereotaxis Inc., St. Louis, MO, USA).
sing a keypad (arrows) or joystick, the catheter can be
ontinuously advanced, retracted or even adjusted (from
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Figure 3. The steerable magnetic ﬁeld contains two giant computer-c
of the ﬂuoroscopy table.
Figure 4. A magnetic ﬁeld of 0.08—0.1 Tesla is generated (accord-
ing to the initial choice), such that the three small magnets that
are incorporated parallel to the tip of the radiofrequency catheter
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or coronary sinus defragmentation or complex fraction-allow for three-dimensional navigation.
1mm to 9mm). The second Niobe II generation allows for
the magnets to be tilted at angles ranging from 40◦ left
anterior oblique to 30◦ right anterior oblique. The constant
application of the magnetic ﬁeld during the ablation pro-
cedure keeps the catheter tip in permanent contact with
the endocardial tissue throughout the cardiac cycle, thus
improving the delivery of the RF current. Because the mag-
netic ﬁeld exerts a weak force (15—20 g) and the catheter is
very ﬂexible, navigation inside the heart is very reliable,
with a near-zero risk of perforation [9—14]. The system
is able to memorize certain data, such as the position of
veins, and reutilize these vectors during the examination to
facilitate catheter navigation or improve procedure times.
In addition, automatic navigation is possible using NaviLine
a
p
controlled 1.8-tonne magnets that are positioned on opposite sides
Stereotaxis Inc., St. Louis, MO, USA), which allows for auto-
atic processing by producing a line or surrounding veins.
easurements: procedural and ﬂuoroscopy
ariables
he following variables were recorded for all patients and
ompared within study groups: total duration time (skin to
kin); total X-ray time and gray/cm2, from needle insertion
o ultimate catheter removal; skin to catheter positioning
-ray time and gray/cm2, from femoral access to the end
f catheter positioning in the left atrium, including transep-
al access; left atrial electroanatomical mapping X-ray time
nd gray/cm2, from catheter positioning in the left atrium
o the creation of a satisfactory electroanatomical recon-
truction compared with a left atrial computed tomography
can; ablation X-ray time and gray/cm2, from the ﬁrst to the
ast RF delivery.
ndpoints
he primary endpoint was wide-area circumferential pul-
onary vein isolation, as conﬁrmed by spiral catheter
ecording during ablation in all patients. Pulmonary vein
solation was deﬁned by abolition or dissociation of activi-
ies in all of the pulmonary veins. Pulmonary vein potentials
nd far-ﬁeld potentials were distinguished with pacing
echnique from the left atrium, left atrial appendage
r coronary sinus, using the ablation or the quadripo-
ar catheter. An additional lesion line (left atrial roof)ted electrograms lesions for persistent AF was possibly
erformed. Secondary endpoints included procedural data,
omplications and freedom from atrial tachycardia (AT)/AF.
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F a vector-based computer system (Navigant system; Stereotaxis Inc., St.
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Table 1 Patient characteristics (n = 81).
Characteristic
Age (years) 60± 9
Women 20
Hypertension 27
Diabetes 7.5
Tobacco 31
Hypercholesterolaemia 30
Atrial ﬁbrillation type
Paroxysmal 73
Persistent 27
CHA2DS2-VASc score 1.2± 1
AF durationa (months) 72± 42
Structural heart disease 25
History of atrial ﬂutter 28.4
LVEF (%) 61± 9
TLAD (mm) 41± 7
Left atrial surface (cm2) 22± 6
Numbera of antiarrhythmic agents tested 2± 1
Data are mean± standard deviation or %. AF: atrial ﬁbrillation;
LVEF: left ventricular ejection fraction; TLAD: transversal left
atrial diameter.
a Median± interquartile.igure 5. The catheter tip may be directed very precisely using
ouis, MO, USA).
ollow-up
atients were routinely hospitalized for 3 days postpro-
edure and a blanking period of 2months was applied.
he blanking period was deﬁned as a period during which
arly recurrences were considered transient phenomena
ather than procedure failures. Antiarrhythmic medica-
ion was maintained for 6months and then discontinued
n patients with paroxysmal AF, but continued in those
ith persistent AF. VKAs were continued, with consider-
tion for the CHA2DS2-VASc score. Success was deﬁned as the
bsence of any documented arrhythmia or symptoms sugges-
ive of arrhythmia recurrences; 24-hour Holter monitoring
as performed each time the patient experienced palpi-
ations. Patients were followed every 6months by means
f a clinical interview and a redo procedure was permit-
ed > 6 months after the index procedure, if the patient so
ished.
tatistical analysis
ll clinical variables were assessed at the time of hospital-
zation and procedure. Continuous variables are presented
s means± standard deviations or medians with interquar-
iles as appropriate. Categorical variables are expressed
s percentages. All analyses were performed using
tatView® 5.0 (StatView IV; Abacus Concept, Berkeley, CA,
SA).
esults
aseline population characteristicsaseline clinical data are summarized in Table 1. In total,
1 patients were prospectively included, with the following
atient characteristics: mean age 60± 9 years; 20% women;
m
h
v
iean left atrial diameter 41± 7mm; and 25% with structural
eart disease. The percentage of circumferential pulmonary
ein isolation, as conﬁrmed by spiral catheter recording dur-
ng ablation, was 97%.
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Total ﬂuoroscopy (median± interquartile)
Median procedure time was 3.5± 1 hours; total X-ray
exposure time was 13± 7minutes (49± 36 gray/cm2);
dual transeptal puncture and catheter positioning time
was 8± 4minutes (29± 22 gray/cm2); left atrial elec-
troanatomical reconstruction time was 1± 4minutes (9± 4
gray/cm2 catheter ablation time was 3.5± 5minutes (11± 2
gray/cm2).
Clinical outcome
After a median follow-up of 15± 6months and the use of
one procedure, 71% of patients were free of symptoms,
while 84% remained asymptomatic after the use of two
or three procedures. The recurrences observed were AT in
three (3.7%) patients, paroxysmal AF in eight (9.9%) patients
and persistent AF in four (4.9%) patients; redo ablation was
performed in these 15 (19%) patients. In two patients with
paroxysmal AF, three procedures were carried out without
clinical success. No tamponade was observed and no char
was noticed on the catheter tip upon catheter removal.
Complications
Access-site groin haematoma was observed in two patients
and one patient had an arteriovenous ﬁstula requiring
surgical revision. Seven days after the procedure, a 71-year-
old patient receiving low-molecular-weight heparin and a
VKA presented a severe psoas haematoma requiring surgi-
cal revision. The postoperative period was unfortunately
complicated by multivisceral failure and the patient died
3weeks later.
Discussion
Major ﬁndings
This study describes the long-term outcome of consecu-
tive patients with AF undergoing remote magnetic ablation
using a new 3D non-ﬂuoroscopic navigation system (Carto 3).
The major ﬁnding was that in patients with paroxysmal or
persistent AF, this new tool yielded results for AF/AT recur-
rence rates that were similar to those previously published
for manual catheter use [24]. Our study provides evidence
that AF ablation with minimal ﬂuoroscopy use is feasible by
means of technology enabling image integration with multi-
ple catheter visualization and RMN.
Potential risks related to X-ray exposure
during atrial ﬁbrillation ablation
Guidelines have recently been modiﬁed to extend the num-
ber of indications for AF ablation [24]. As a result, the
increased number of AF ablation indications has logically
led to an increased number of procedures per centre.
Accordingly, patients and medical staff are prone to signif-
icant radiation exposure. Moreover, many patients undergo
multiple examinations and interventional procedures that
increase their cumulative dose and overall radiation risks.
Thus, radiation exposure to the skin in patients undergoing
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F ablation or in physicians may exceed the thresholds for
adiation skin injuries due to prolonged ﬂuoroscopic times
25—27]. The additional lifetime risk for a fatal malignancy
ssociated with a single AF ablation has been estimated to
ange between 0.15% and 0.21% [25—27]. The individual can-
er risk (fatal and non-fatal) has been estimated to be close
o 1/200 [28] and, consequently, current guidelines recom-
end that all physicians minimize radiation injury hazard
o patients and medical or professional staff [29]. Conse-
uently, the ability to integrate RMN and electroanatomical
avigation plus catheter visualization (Carto 3 system) bears
reat potential for the development of quicker anatomy-
peciﬁc ablation procedures and shorter ﬂuoroscopic times.
mpact of remote magnetic navigation on
trial ﬁbrillation procedures
ne of the principal advantages reported in the literature
s the highly signiﬁcant decrease in X-ray exposure [9—14].
his observation may appear trivial when considering the
hort-term effects for patients, but in cases where multiple
nterventions using radiation are performed, it could rep-
esent a very signiﬁcant decrease in total X-ray exposure
ime for the physician and patient [24—29]. This observa-
ion is even more pertinent for electrophysiologists, whose
ultidisciplinary activities might include implantation of
esynchronization devices and ablation of complex arrhyth-
ias, with obvious long-term beneﬁts [9]. The amplitude of
he reduction in X-ray exposure was evaluated to be 50%
n average [30,31]. Similar results were published by Kim
t al., who reported a mean reduction of 29minutes com-
ared with the conventional method [32]. Despite lacking a
ontrol group, our study ﬁndings show that the new technol-
gy allows AF procedures to be performed with a very short
-ray exposure (median 3± 4minutes; 10 gray/cm2), which
nvolves left atrial acquisition map and AF ablation times.
n the scientiﬁc literature, the procedure times with this
ew technology were reported to be longer than those with
he conventional method. However, in the reported stud-
es, there were some biases associated with the research.
ighly experienced groups performed these studies, gener-
lly involving several operators, including ‘fellows’, and the
earning curve was integrated, which renders the analysis of
he results difﬁcult. Although the procedure time appears
o be a decisive measurement, operator fatigue should also
e included in the evaluation. In retrospect, it appears to us
hat magnetic navigation had a major impact on this latter
ariable, enabling us to signiﬁcantly increase our activity,
hile reducing the level of operator fatigue at the end of
he day. Di Biase et al. showed that using RMN reduced
uoroscopy time very signiﬁcantly during AF ablation and
hen the learning curve was overcome, the amelioration
as shown to be highly signiﬁcant [33]. Our results conﬁrm
hat RF ablation procedures can be performed with a low
evel of X-ray exposure and operator fatigue. Concerning
afety, utilization of a ﬂexible magnetic catheter consider-
bly increased the safety of complex procedures such as RF
blation in AF [34—36]. The risk of perforation was almost
ero and was more due to the softness of the catheter
han to the constant force applied to the tissue, which
id not exceed 15—20 g [9,35]. Cases of catheter-induced
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amponade have been rarely reported in the literature
9,35]. In approximately 300 AF ablation procedures car-
ied out in our laboratory using the Stereotaxis system, only
ne case of tamponade was observed, which occurred during
ranseptal catheterization. The RMN results reported from
he different studies appear to be similar to those for the
onventional method, without being superior [9,35]. Based
n our study results, primary success was achieved in 71%
f cases and 84% of patients remained asymptomatic dur-
ng long-term follow-up (median 15months). These results
hould be viewed in context: the operators had considerably
ore experience with the manual method [9,35]. Moreover,
ecause certain theoretical advantages, such as the stabil-
ty of the catheter, access to difﬁcult zones such as the
ight inferior pulmonary vein, the quality of the practiced
ines and lesion homogeneity [9,35], appear to favour mag-
etic navigation, we must wait for the outcomes of ongoing
rospective studies using both methods and conducted in
xperienced centres to truly answer the question.
mpact of electroanatomical mapping systems
n X-ray exposure and procedure times
ven in experienced hands, conventional ﬂuoroscopic-
uided ablation is a lengthy procedure requiring extensive
se of ﬂuoroscopy. Electroanatomical maps and the inte-
ration of 3D cardiac images (magnetic resonance imaging
r computed tomography scan) show great potential for
educing both procedure and X-ray exposure times [15—23].
n previous versions of the electroanatomical mapping
ystem (Carto XP EP mapping system; Biosense Webster,
A, USA), visualization was possible only for the abla-
ion catheter tip by means of electromagnetic technology
15—20,22,23]. The inability to visualize multiple catheters
equired routine validation of the Lasso catheter posi-
ion by means of ﬂuoroscopy, thereby prolonging radiation
xposure [15—20,22,23]. The Carto 3 system combines
he electromagnetic technology (as in the Carto XP sys-
em) with new advanced catheter location technology that
nables visualization of multiple catheters without ﬂuo-
oscopy [21,34,37]. Left atrial reconstruction was obtained
sing a fast anatomical map algorithm [37]. The the-
retical advantages of old and new electroanatomical
ystems have not been fully proven in clinical practice
21,34,38—40]. Indeed, despite the signiﬁcant reduction in
uoroscopic times, clinical studies failed to demonstrate
reduction in procedure duration or an improvement in
linical outcomes [21,34,38—40]. Our study is in accor-
ance with previously published reports, but emphasizes the
ow level of X-ray exposure. The residual X-ray exposure
as essentially due to the need to conﬁrm pulmonary vein
solation by mobilizing the circumferential Lasso mapping
atheter. Recently, a remote circular catheter manipulation
ystem was developed to prevent manual catheter manip-
lation (Vdrive robotic system; Stereotaxis; St. Louis, MO,
SA) [41].
linical implicationshile catheter ablation to isolate pulmonary veins has
ecome the therapy of choice for managing drug-refractory
ymptomatic AF, it is still considered to be a second-line
c
h
c
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reatment, according to the latest guidelines [24]. Even
xperienced operators can ﬁnd achieving a successful out-
ome without unnecessary adverse events very challenging
hen using this procedure [24]. Given this context, our
tudy has shown that the combination of RMN and elec-
roanatomical technology enabling visualization of multiple
atheters without ﬂuoroscopy (Carto 3 system) is feasi-
le with reduced X-ray exposure time and no additional
omplications compared with manual procedures. In our
tudy, this strategy was shown to result in an AF/AT recur-
ence rate that was similar to that with the manual method,
s previously reported [9,30,42—44], but with signiﬁcan-
ly reduced X-ray exposure. Accordingly, the combination
f Carto 3 and RMN represents the optimal tool for per-
orming effective AF ablation, with the ultimate aim of
educing patient and operator X-ray exposure and limit-
ng operator fatigue. In retrospect, it appears to us that
agnetic navigation has a major impact on this latter vari-
ble, allowing us to signiﬁcantly increase our activity, while
educing the level of operator fatigue at the end of the
ay.
tudy limitations
he major limitations of this study are its non-randomized
esign and the small sample size based on an indirect
omparison with previously published results. However, ran-
omized studies are difﬁcult to conduct due to the low
umber of centres beneﬁting from RMN in France. To
ur knowledge, no prospective studies on the feasibility,
afety and efﬁcacy achieved with the combination of RMN
nd Carto 3 have been published to date. Despite lack-
ng a comparative manual control group, our results appear
ncouraging. However, a large multicentre randomized com-
arative study must be performed to conﬁrm these positive
reliminary results. Even if the easier approach of sites that
re difﬁcult to reach manually is conﬁrmed, sites such as the
ight inferior pulmonary vein are tackled at the expense of
ontact force (distal magnet only) owing to the close prox-
mity of the transeptal puncture site, unless a curve is made
y the catheter in the left atrium. Experience demonstrates
hat such a curve is unstable and requires the more recently
ntroduced VCAS Deﬂect (Stereotaxis; St. Louis, MO, USA).
he major ﬁndings are based on an indirect comparison with
reviously published results.
onclusions
MN with irrigated catheters combined with the Carto 3 sys-
em can be effectively performed in patients requiring AF
blation with minimal use of ﬂuoroscopy, but larger random-
zed studies are warranted.
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